|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 非维生素K拮抗与维生素K拮抗口服抗凝剂与脑出血患者住院死亡之间的关系显示文摘尽管非维生素K拮抗口服抗凝剂(non-vitamin K antagonist oral anticoagulants, NOACs)越来越多地应用于预防血栓栓塞性疾病,但关于NOACs相关性脑出血的数据仍然有限。 | 刘青 叶鹏 Inohara T Xian Y Liang L Matsouaka RA Saver JL Smith EE Schwamm LH Reeves MJ Hernandez AF Bhatt DL Peterson ED Fonarow GC | 2018 | 中华高血压杂志2018，26，2： | 16 |
| 2 | Potential impact of optimal implementation of evidence-based heart failure therapies on mortality显示文摘 | Fonarow GC Yancy CW Hernandez AF | 2011 | AmHeartJ2011，161，6： | 1 |
| 3 | Relationship between early physician follow - up and 30 - day readmission among Medicare beneficiaries hospitalized for heart failure显示文摘 | Hernandez AF Greiner MA Fonarow GC | 2010 | JAMA2010，303，17： | 1 |
| 4 | Relationship between early physician follow-up and 30-dayreadmission among medicare beneficiaries hospitalized forheart failure显示文摘 | Hernandez AF Greiner MA Fonarow GC | 2010 | JAMA2010，303，17： | 1 |
| 5 | Sex and racila differences in the use of implantable cardioverter defibrillators among patients hospitalized with heart failure显示文摘 | Hernandez AF Fonarow GC Liang L | 2007 | JAMA2007，298，13： | 1 |
| 6 | Quality of care for acute coronary syn- drome patients with known atherosclerotic disease: Results from the get with the guidelines program显示文摘 | Brilakis ES Hernandez AF Dai D Peterson ED Banerjee S Fonarow GC Cannon CP Bhatt DL | 2009 | Circulation2009，120，： | 1 |
| 7 | Relationship between early physician follow-up and 30-day redmission among Medicare beneficiaries hospitalized for heart failure显示文摘 | Hernandez AF Greiner MA Fonarow GC | | Journal of the American Medical Association0，，： | 1 |
| 8 | Changes in the systemic immunologic response in association with endometriosis using an animal model显示文摘 | Hernandez GC Vadillo OF Tlapanco BR | 2002 | Ginecol Obstet Mex2002，70，： | 1 |
| 9 | Apoptosis in trophoblast of patients with recurrent spontaneous abortion of unidentified cause显示文摘 | Vadillo OF Avila VM Hernandez GC | 2000 | Ginecol Obstet Mex2000，68，： | 1 |
| 10 | Apoptosis in trophoblast of patients with recurrent spontaneous abortion of unidentified cause显示文摘 | Vadillo OF Avila-Vergara MA Hernandez GC | 2000 | Gynecol Obstet Mex2000，68，： | 1 |
| 11 | Potential impact of optimal implementation of evidence-based heart failure therapies on mortality显示文摘 | Fonarow GC Yancy CW Hernandez AF | 2011 | AmHeartJ2011，161，6： | 1 |
| 12 | Genetic variability of Rhizoctonia solani Kühn and its resistance to fungicides显示文摘The aims of this study are to determine the population genetic structure of Rhizoctonia solani,associated with potato,and to assess its resistance degree to pencycuron and thiabendazole fungicides.A total of 57 strains of R.Solani were isolated from different potato crop fields in Mexico,and were classified according to their anastomosis group(AG)using the polymerase chain reaction(PCR)and restriction fragment length polymorphism(RFLP)-based analysis.Then,the amplified fragments were digested with four different endonucleases(Mse I,Ava II,Mun I and Hinc II).The Repetitive Element Sequence-Based PCR(rep-PCR)technique was used to determine the genetic diversity in R.solani populations.Results obtained by PCR-RFLP showed that 81%of the isolates were identified as belonging to AG-3 group,14%to AG1-1B and 5%to AG-11 group.In response to fungicides inhibition,IC_(50)between 0.014-0.039 mg a.i./L for pencycuron,and 0.82 to 2.91 for thiabendazole were determined,This IC_(50)value showed that the resistance factor(RF)values ranged from 1.4 to 3.945 and 0.27 to 0.97,respectively;this tendency suggests that isolates are susceptible to thiabendazole.The AG groups showed a heterogeneous resistance to pencycuron and thiabendazole,being more tolerant to these fungicides AG1-1B and AG-11 groups.The genetic analysis shows a low genetic diversity among(P-value 0.3225)and within(P-value 0.3275)populations;this can indicate a clonal reproduction and little parasexual cycle among the analyzed isolations. | Castillo RF Gallegos G Flores OA Aguilar GC Rodriguez HR Hernandez CFD | 2020 | Studies in Fungi2020，5，1： | 0 |
| 13 | Prospective application of a bleeding and ischemic risks-adjusted antithrombotic protocol in elderly patients revascularized with everolimus-eluting stents:EPIC05-Sierra75 study显示文摘OBJECTIVES Elderly patients show a higher incidence of ischemic and bleeding events after percutaneous transluminal coron-ary intervention(PCI).We sought to investigate outcomes in elderly patients treated with antithrombotic strategy guided by bleeding and ischemic risks after revascularization with last generation everolimus-eluting stent(EES).METHODS Prospective multicenter registry including patients over 75 years revascularized with EES and antithrombotic ther-apy guided by clinical presentation,PCI complexity and PRECISE DAPT score.Co-primary safety endpoints were:(1)composite of cardiac death,myocardial infarction and stent thrombosis and;(2)bleeding(BARC 2-5).Primary efficacy endpoint was target lesion revascularization.A matched group of patients revascularized with current drug-eluting stents and no such tailored antith-rombotic therapy was used as control.RESULTS Finally,1064 patients were included in SIERRA-75 cohort,80.8±4.2 years,36.6%women,71%acute coronary syn-dromes(ACS)and 53.6%complex PCI.Co-primary safety endpoint of major adverse cardiovascular events was met in 6.2%,co-primary safety endpoint of bleeding in 7.8%and primary efficacy endpoint of TKLR in 1.5%.The multivariable adjusted model showed no significant association of the prescribed short/long dual antiplatelet therapy(DAPT)durations with any endpoint suggesting a well tailored therapy.No stent thrombosis reported in the subgroup with 1-3 months DAPT duration.As compared to control group,bleeding BARC 2-5 was significantly lower in SIERRA-75 group(7.4%vs.10.2%,P=0.04)as well as the net safety-efficacy endpoint(14.3%vs.18.5%,P=0.02).CONCLUSIONS In elderly population,the application of this risks-adjusted antithrombotic protocol after revascularization with last generation EES seems to be associated with an improved prognosis in terms of ischemic and bleeding outcomes. | Jose M de la Torre Hernandez Ramon Lopez Palop Jesus M Jimenez Mazuecos Pilar Carrillo Sáez Alejandro Gutierez-Barrios Eduardo Pinar Belen Cid Luis Fernandez Tamara Garcia Camarero Cristóbal Urbano-Carrillo Juan F Oteo Dominguez Victor A Jimenez Diaz Antonio EGomez Menchero Eladio Galindo Fernández Juan GCórdoba Soriano Raymundo Ocaranza Eduardo ArroyoÚcar Koldobika Garcia San Roman Silvio Leal Ginés Martínez Cáceres Jose A Linares Vicente Georgina Fuertes Ferre Xavier Carrillo Juan CRama Merchán Catia Costa Juan Sanchis Renato Fernandes Alberto Rodrigues Jose M Vegas Valle Hélder Pereira Armando Perez de Prado | 2022 | Journal of Geriatric Cardiology2022，19，5： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员